Gastroesophageal reflux in infants: More than just a pHenomenon

JAMA Pediatrics

Volumn 168, Issue 1, 2014, Pages 83-89

  Rosen, Rachel ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL FEATURE; CONSERVATIVE TREATMENT; DIAGNOSIS; GASTROESOPHAGEAL REFLUX; HEALTH CARE PERSONNEL; HUMAN; MEDICAL SPECIALIST; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; STOMACH ACID;

GASTROESOPHAGEAL REFLUX; HUMANS; HYDROGEN-ION CONCENTRATION; INFANT;

EID: 84892738767     PISSN: 21686203     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapediatrics.2013.2911     Document Type: Article

References (82)

1. Nelson SP, Chen EH, Syniar GM, Christoffel KK; Pediatric Practice Research Group. Prevalence of symptoms of gastroesophageal reflux during infancy: a pediatric practice-based survey. Arch Pediatr Adolesc Med. 1997;151(6):569-572. (Pubitemid 27262280)
2. Nelson SP, Kothari S, Wu EQ, Beaulieu N, McHale JM, Dabbous OH. Pediatric gastroesophageal reflux disease and acid-related conditions. J Med Econ. 2009;12(4):348-355.
3. Vandenplas Y, Rudolph CD, Di Lorenzo C, et al; North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition; European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. Pediatric gastroesophageal reflux clinical practice guidelines. J Pediatr Gastroenterol Nutr. 2009;49(4):498-547.
4. Martin AJ, Pratt N, Kennedy JD, et al. Natural history and familial relationships of infant spilling to 9 years of age. Pediatrics. 2002;109(6):1061-1067. (Pubitemid 34587431)
5. Campanozzi A, Boccia G, Pensabene L, et al. Prevalence and natural history of gastroesophageal reflux. Pediatrics. 2009;123(3):779-783.
6. Omari TI, Barnett C, Snel A, et al. Mechanisms of gastroesophageal reflux in healthy premature infants. J Pediatr. 1998;133(5):650-654. (Pubitemid 28521215)
7. Omari TI, Barnett CP, Benninga MA, et al. Mechanisms of gastro-oesophageal reflux in preterm and term infants with reflux disease. Gut. 2002;51(4):475-479.
8. Omari TI, Rommel N, Staunton E, et al. Paradoxical impact of body positioning on gastroesophageal reflux and gastric emptying in the premature neonate. J Pediatr. 2004;145(2): 194-200. (Pubitemid 38993391)
9. Rodbro P, Krasilnikoff PA, Christiansen PM. Parietal cell secretory function in early childhood. Scand J Gastroenterol. 1967;2(3):209-213.
10. Boyle JT. Acid secretion from birth to adulthood. J Pediatr Gastroenterol Nutr. 2003;37(suppl 1):S12-S16.
11. Agunod M, Yamaguchi N, Lopez R, Luhby AL, Glass GB. Correlative study of hydrochloric acid, pepsin, and intrinsic factor secretion in newborns and infants. Am J Dig Dis. 1969;14(6):400-414.
12. Orenstein SR, Shalaby TM, Cohn JF. Reflux symptoms in 100 normal infants: diagnostic validity of the infant gastroesophageal reflux questionnaire. Clin Pediatr (Phila). 1996;35(12):607-614. (Pubitemid 27014639)
13. Aksglaede K, Pedersen JB, Lange A, Funch-Jensen P, Thommesen P. Gastro-esophageal reflux demonstrated by radiography in infants less than 1 year of age. Acta Radiol. 2003;44(2):136-138.
14. Faure C, Michaud L, Shaghaghi EK, et al. Lansoprazole in children: pharmacokinetics and efficacy in reflux oesophagitis. Aliment Pharmacol Ther. 2001;15(9):1397-1402. (Pubitemid 32835547)
15. Vandenplas Y, Franckx-Goossens A, Pipeleers-Marichal M, Derde MP, Sacré-Smits L. Area under pH 4: advantages of a new parameter in the interpretation of esophageal pH monitoring data in infants. J Pediatr Gastroenterol Nutr. 1989;9(1):34-39. (Pubitemid 19166687)
16. Black DD, Haggitt RC, Orenstein SR, Whitington PF. Esophagitis in infants: morphometric histological diagnosis and correlation with measures of gastroesophageal reflux. Gastroenterology. 1990;98(6):1408-1414. (Pubitemid 20158600)
17. Salvatore S, Hauser B, Vandemaele K, Novario R, Vandenplas Y. Gastroesophageal reflux disease in infants: how much is predictable with questionnaires, pH-metry, endoscopy and histology? J Pediatr Gastroenterol Nutr. 2005;40(2):210-215. (Pubitemid 40269744)
18. Orenstein SR, Shalaby TM, Kelsey SF, Frankel E. Natural history of infant reflux esophagitis: symptoms and morphometric histology during one year without pharmacotherapy. Am J Gastroenterol. 2006;101(3):628-640. (Pubitemid 43340942)
19. Vandenplas Y, Badriul H, Verghote M, Hauser B, Kaufman L. Oesophageal pH monitoring and reflux oesophagitis in irritable infants. Eur J Pediatr. 2004;163(6):300-304. (Pubitemid 38725534)
20. Arana A, Bagucka B, Hauser B, et al. pH Monitoring in the distal and proximal esophagus in symptomatic infants. J Pediatr Gastroenterol Nutr. 2001;32(3):259-264. (Pubitemid 32374301)
21. Harris P, Muñoz C, Mobarec S, Brockmann P, Mesa T, Sánchez I. Relevance of the pH probe in sleep study analysis in infants. Child Care Health Dev. 2004;30(4):337-344. (Pubitemid 38960809)
22. Kahn A, Rebuffat E, Sottiaux M, Dufour D, Cadranel S, Reiterer F. Lack of temporal relation between acid reflux in the proximal oesophagus and cardiorespiratory events in sleeping infants. Eur J Pediatr. 1992;151(3):208-212.
23. Heine RG, Jordan B, Lubitz L, Meehan M, Catto-Smith AG. Clinical predictors of pathological gastro-oesophageal reflux in infants with persistent distress. J Paediatr Child Health. 2006;42(3): 134-139. (Pubitemid 43356868)
24. Vaezi MF, Schroeder PL, Richter JE. Reproducibility of proximal probe pH parameters in 24-hour ambulatory esophageal pH monitoring. Am J Gastroenterol. 1997;92(5):825-829. (Pubitemid 27200799)
25. Rosen R, Lord C, Nurko S. The sensitivity of multi-channel intraluminal impedance and the pH probe in the evaluation of gastroesophgeal reflux in children. Clin Gastroenterol Hepatol. 2006;4(2):167-172. (Pubitemid 43199686)
26. Wenzl TG, Moroder C, Trachterna M, et al. Esophageal pH monitoring and impedance measurement: a comparison of two diagnostic tests for gastroesophageal reflux. J Pediatr Gastroenterol Nutr. 2002;34(5):519-523. (Pubitemid 34596220)
27. Peter CS, Sprodowski N, Bohnhorst B, Silny J, Poets CF. Gastroesophageal reflux and apnea of prematurity. Pediatrics. 2002;109(1):8-11.
28. Loots CM, Benninga MA, Davidson GP, Omari TI. Addition of pH-impedance monitoring to standard pH monitoring increases the yield of symptom association analysis in infants and children with gastroesophageal reflux. J Pediatr. 2009;154(2):248-252.
29. Wenzl TG, Schenke S, Peschgens T, Silny J, Heimann G, Skopnik H. Association of apnea and nonacid gastroesophageal reflux in infants: investigations with the intraluminal impedance technique. Pediatr Pulmonol. 2001;31(2):144-149.
30. Mousa H, Woodley F, Metheney M, Hayes J. Testing the association between gastroesophageal reflux and apnea in infants. J Pediatr Gastroenterol Nutr. 2005;41(2):169-177. (Pubitemid 41099364)
31. Slocum C, Arko M, Di Fiore J, Martin RJ, Hibbs AM. Apnea, bradycardia and desaturation in preterm infants before and after feeding. J Perinatol. 2009;29(3):209-212.
32. Omari TI, Schwarzer A, van Wijk MP, et al. Optimisation of the reflux-symptom association statistics for use in infants being investigated by 24-hour pH impedance. J Pediatr Gastroenterol Nutr. 2011;52(4):408-413.
33. Orenstein SR, Whitington PF, Orenstein DM. The infant seat as treatment for gastroesophageal reflux. N Engl J Med. 1983;309(13):760-763. (Pubitemid 13004284)
34. Ewer AK, James ME, Tobin JM. Prone and left lateral positioning reduce gastro-oesophageal reflux in preterm infants. Arch Dis Child Fetal Neonatal Ed. 1999;81(3):F201-F205. (Pubitemid 29503329)
35. Vandenplas Y, Sacre-Smits L. Seventeen-hour continuous esophageal pH monitoring in the newborn: evaluation of the influence of position in asymptomatic and symptomatic babies. J Pediatr Gastroenterol Nutr. 1985;4(3):356-361. (Pubitemid 15064021)
36. Corvaglia L, Rotatori R, Ferlini M, Aceti A, Ancora G, Faldella G. The effect of body positioning on gastroesophageal reflux in premature infants. J Pediatr. 2007;151(6):591-596.e1. doi:10.1016/j.jpeds.2007.06.014. (Pubitemid 350116136)
37. Loots C, Smits M, Omari T, Bennink R, Benninga M, VanWijk M. Effect of lateral positioning on gastroesophageal reflux (GER) and underlying mechanisms in GER disease (GERD) patients and healthy controls. Neurogastroenterol Motil. 2013;25(3):222-229, e161-e162. doi:10.1111/nmo.12042.
38. van Wijk MP, Benninga MA, Dent J, et al. Effect of body position changes on postprandial gastroesophageal reflux and gastric emptying in the healthy premature neonate. J Pediatr. 2007;151(6):585-590.e1-e2. doi:10.1016/j.jpeds. 2007.06.015. (Pubitemid 350123542)
39. American Academy of Pediatrics Task Force on Sudden Infant Death Syndrome. The changing concept of sudden infant death syndrome. Pediatrics. 2005;116(5):1245-1255.
40. Chao HC, Vandenplas Y. Effect of cereal-thickened formula and upright positioning on regurgitation, gastric emptying, and weight gain in infants with regurgitation. Nutrition. 2007;23(1):23-28. (Pubitemid 44959770)
41. Khan BA, Sodhi JS, Zargar SA, et al. Effect of bed head elevation during sleep in symptomatic patients of nocturnal gastroesophageal reflux. J Gastroenterol Hepatol. 2012;27(6):1078-1082.
42. Centers for Disease Control and Prevention (CDC). Suffocation deaths associated with use of infant sleep positioners. MMWR Morb Mortal Wkly Rep. 2012;61(46):933-937.
43. Hamilton JW, Boisen RJ, Yamamoto DT, Wagner JL, Reichelderfer M. Sleeping on a wedge diminishes exposure of the esophagus to refluxed acid. Dig Dis Sci. 1988;33(5):518-522.
44. Bailey DJ, Andres JM, Danek GD, Pineiro-Carrero VM. Lack of efficacy of thickened feeding as treatment for gastroesophageal reflux. J Pediatr. 1987;110(2):187-189. (Pubitemid 17016843)
45. Orenstein SR, Magill HL, Brooks P. Thickening of infant feedings for therapy of gastroesophageal reflux. J Pediatr. 1987;110(2):181-186. (Pubitemid 17016842)
46. Xinias I, Mouane N, Le Luyer B, et al. Cornstarch thickened formula reduces oesophageal acid exposure time in infants. Dig Liver Dis. 2005;37(1):23-27. (Pubitemid 41070560)
47. Wenzl TG, Schneider S, Scheele F, Silny J, Heimann G, Skopnik H. Effects of thickened feeding on gastroesophageal reflux in infants: a placebo-controlled crossover study using intraluminal impedance. Pediatrics. 2003;111(4, pt 1):e355-e359.
48. Corvaglia L, Spizzichino M, Aceti A, et al. A thickened formula does not reduce apneas related to gastroesophageal reflux in preterm infants. Neonatology. 2013;103(2):98-102.
49. Jadcherla SR, Chan CY, Moore R, Malkar M, Timan CJ, Valentine CJ. Impact of feeding strategies on the frequency and clearance of acid and nonacid gastroesophageal reflux events in dysphagic neonates. JPEN J Parenter Enteral Nutr. 2012;36(4):449-455.
50. Hill DJ, Hudson IL, Sheffield LJ, Shelton MJ, Menahem S, Hosking CS. A low allergen diet is a significant intervention in infantile colic. J Allergy Clin Immunol. 1995;96(6, pt 1):886-892.
51. Jakobsson I, Lothe L, Ley D, Borschel MW. Effectiveness of casein hydrolysate feedings in infants with colic. Acta Paediatr. 2000;89(1):18-21. (Pubitemid 30060623)
52. Lucassen PL, Assendelft WJ, Gubbels JW, van Eijk JT, Douwes AC. Infantile colic: crying time reduction with a whey hydrolysate: a double-blind, randomized, placebo-controlled trial. Pediatrics. 2000;106(6):1349-1354.
53. Borrelli O, Mancini V, Thapar N, et al. Cow's milk challenge increases weakly acidic reflux in children with cow'smilk allergy and gastroesophageal reflux disease. J Pediatr. 2012;161(3):476-481.e1. doi:10.1016/j.jpeds.2012.03. 002.
54. Tolia V, Youssef NN, Gilger MA, Traxler B, Illueca M. Esomeprazole for the treatment of erosive esophagitis in children: an international, multicenter, randomized, parallel-group, double-blind (for dose) study. BMC Pediatr. 2010;10:41. doi:10.1186/1471-2431-10-41.
55. Omari T, Davidson G, Bondarov P, Nauclér E, Nilsson C, Lundborg P. Pharmacokinetics and acid-suppressive effects of esomeprazole in infants 1-24 months old with symptoms of gastroesophageal reflux disease. J Pediatr Gastroenterol Nutr. 2007;45(5):530-537. (Pubitemid 350307137)
56. Omari TI, Haslam RR, Lundborg P, Davidson GP. Effect of omeprazole on acid gastroesophageal reflux and gastric acidity in preterm infants with pathological acid reflux. J Pediatr Gastroenterol Nutr. 2007;44(1):41-44. (Pubitemid 46071790)
57. Orenstein SR, Shalaby TM, Devandry SN, et al. Famotidine for infant gastro-oesophageal reflux: a multi-centre, randomized, placebo-controlled, withdrawal trial. Aliment Pharmacol Ther. 2003;17(9):1097-1107. (Pubitemid 36605746)
58. Jordan B, Heine RG, Meehan M, Catto-Smith AG, Lubitz L. Effect of antireflux medication, placebo and infant mental health intervention on persistent crying: a randomized clinical trial. J Paediatr Child Health. 2006;42(1-2):49-58.
59. Winter H, Kum-Nji P, Mahomedy SH, et al. Efficacy and safety of pantoprazole delayed-release granules for oral suspension in a placebo-controlled treatment-withdrawal study in infants 1-11 months old with symptomatic GERD. J Pediatr Gastroenterol Nutr. 2010;50(6):609-618.
60. Moore DJ, Tao BS, Lines DR, Hirte C, Heddle ML, Davidson GP. Double-blind placebo-controlled trial of omeprazole in irritable infants with gastroesophageal reflux. J Pediatr. 2003;143(2):219-223. (Pubitemid 37082956)
61. Orenstein SR, Hassall E, Furmaga-Jablonska W, Atkinson S, Raanan M. Multicenter, double-blind, randomized, placebo-controlled trial assessing the efficacy and safety of proton pump inhibitor lansoprazole in infants with symptoms of gastroesophageal reflux disease. J Pediatr. 2009;154(4):514-520.e4. doi:10.1016/j.jpeds.2008.09.054.
62. Canani RB, Cirillo P, Roggero P, et al;Working Group on Intestinal Infections of the Italian Society of Pediatric Gastroenterology, Hepatology and Nutrition (SIGENP). Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children. Pediatrics. 2006;117(5):e817-e820. doi:10.1542/peds.2005-1655. (Pubitemid 46071346)
63. Holbrook JT, Wise RA, Gold BD, et al;Writing Committee for the American Lung Association Asthma Clinical Research Centers. Lansoprazole for children with poorly controlled asthma: a randomized controlled trial. JAMA. 2012;307(4):373-381.
64. Tolia V, Calhoun J, Kuhns L, Kauffman RE. Randomized, prospective double-blind trial of metoclopramide and placebo for gastroesophageal reflux in infants. J Pediatr. 1989;115(1):141-145. (Pubitemid 19177986)
65. Machida HM, Forbes DA, Gall DG, Scott RB. Metoclopramide in gastroesophageal reflux of infancy. J Pediatr. 1988;112(3):483-487. (Pubitemid 18079844)
66. Cohen S, Morris DW, Schoen HJ, DiMarino AJ. The effect of oral and intravenous metoclopramide on human lower esophageal sphincter pressure. Gastroenterology. 1976;70(4):484-487.
67. Rohof WO, Bennink RJ, de Ruigh AA, Hirsch DP, Zwinderman AH, Boeckxstaens GE. Effect of azithromycin on acid reflux, hiatus hernia and proximal acid pocket in the postprandial period. Gut. 2012;61(12):1670-1677.
68. Ng SC, Gomez JM, Rajadurai VS, Saw SM, Quak SH. Establishing enteral feeding in preterm infants with feeding intolerance: a randomized controlled study of low-dose erythromycin. J Pediatr Gastroenterol Nutr. 2003;37(5):554-558. (Pubitemid 39280860)
69. Mansi Y, Abdelaziz N, Ezzeldin Z, Ibrahim R. Randomized controlled trial of a high dose of oral erythromycin for the treatment of feeding intolerance in preterm infants. Neonatology. 2011;100(3):290-294.
70. Ng PC. Use of oral erythromycin for the treatment of gastrointestinal dysmotility in preterm infants. Neonatology. 2009;95(2):97-104.
71. Cooper WO, Griffin MR, Arbogast P, Hickson GB, Gautam S, RayWA. Very early exposure to erythromycin and infantile hypertrophic pyloric stenosis. Arch Pediatr Adolesc Med. 2002;156(7):647-650. (Pubitemid 34755991)
72. Centers for Disease Control and Prevention (CDC). Hypertrophic pyloric stenosis in infants following pertussis prophylaxis with erythromycin: Knoxville, Tennessee, 1999. MMWR Morb Mortal Wkly Rep. 1999;48(49):1117-1120.
73. Kazerooni NL, VanCamp J, Hirschl RB, Drongowski RA, Coran AG. Fundoplication in 160 children under 2 years of age. J Pediatr Surg. 1994;29(5):677-681. (Pubitemid 24148466)
74. Fung KP, Seagram G, Pasieka J, Trevenen C, Machida H, Scott B. Investigation and outcome of 121 infants and children requiring Nissen fundoplication for the management of gastroesophageal reflux. Clin Invest Med. 1990;13(5):237-246. (Pubitemid 20367950)
75. Goldin AB, Sawin R, Seidel KD, Flum DR. Do antireflux operations decrease the rate of reflux-related hospitalizations in children? Pediatrics. 2006;118(6):2326-2333. (Pubitemid 46397570)
76. Lee SL, Shabatian H, Hsu JW, Applebaum H, Haigh PI. Hospital admissions for respiratory symptoms and failure to thrive before and after Nissen fundoplication. J Pediatr Surg. 2008;43(1):59-65.
77. Valusek PA, St Peter SD, Tsao K, Spilde TL, Ostlie DJ, Holcomb GWIII. The use of fundoplication for prevention of apparent life-threatening events. J Pediatr Surg. 2007;42(6):1022-1025. (Pubitemid 46856449)
78. Zimbric G, Bonkowsky JL, Jackson WD, Maloney CG, Srivastava R. Adverse outcomes associated with gastroesophageal reflux disease are rare following an apparent life-threatening event. J Hosp Med. 2012;7(6):476-481.
79. Rosen R, Hart K, Warlaumont M. Incidence of gastroesophageal reflux during transpyloric feeds. J Pediatr Gastroenterol Nutr. 2011;52(5):532-535.
80. Malcolm WF, Smith PB, Mears S, Goldberg RN, Cotten CM. Transpyloric tube feeding in very low birthweight infants with suspected gastroesophageal reflux: impact on apnea and bradycardia. J Perinatol. 2009;29(5):372-375.
81. Misra S, Macwan K, Albert V. Transpyloric feeding in gastroesophageal- reflux-associated apnea in premature infants. Acta Paediatr. 2007;96(10):1426-1429. (Pubitemid 47416420)
82. Srivastava R, Downey EC, O'Gorman M, et al. Impact of fundoplication versus gastrojejunal feeding tubes on mortality and in preventing aspiration pneumonia in young children with neurologic impairment who have gastroesophageal reflux disease. Pediatrics. 2009;123(1):338-345.